Elanco Animal Health Inc. (ELAN) is a renowned global animal health company that develops, manufactures, and markets products for companion and food animals. Incorporated in 2018 and headquartered in Greenfield, Indiana, Elanco is committed to improving animal health. Through innovative products and services, it ensures the well-being of pets and livestock, indirectly benefiting humans who depend on these animals for companionship, food, and other necessities.
Elanco initially started as a division of pharmaceutical giant Eli Lilly and Company. Following its spinoff and its initial public offering, it became an independent entity and competes with leading manufacturers in the animal health sector. Elanco's range of products is extensive, covering vaccines, nutritional supplements, parasite control, therapies, disease management, and animal-only antibiotics.
Elanco's mission is to improve the lives of animals, which in turn enhances the lives of the people who care for them. The corporation operates in more than 90 countries, and its dietary supplements and veterinary medicines are sold in over 100 countries, making it a truly global company.
At the heart of Elanco's operations is innovation. It continuously works to develop new products and improve its existing ones, carry out disease control research, and promote sustainable livestock production. From enhancing animal performance to preventing and controlling diseases that threaten animal populations, Elanco’s innovative solutions continue to make a profound impact worldwide.
Concerning corporate responsibility, Elanco has a comprehensive approach that includes contributing to global food security, promoting responsible antibiotic use, and reducing its environmental footprint. At the company's core are its four guiding principles: food and companionship, enriching life, responsibility, and innovation.
Financially, Elanco has positioned itself as one of the largest players in the animal health industry. Notably, in 2020 Elanco completed the acquisition of Bayer Animal Health, showcasing the company’s strategic expansion plans. This acquisition has established Elanco as a leader in the pet health industry, bolstering its market presence.
In conclusion, Elanco Animal Health Inc. (ELAN) is a pioneering company, transforming the lives of animals and people around the globe. With its dedication to innovation, responsibility, and quality healthcare products, Elanco is poised to continue leading the way in animal health.